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ABSTRACT
This study examined the hydrolysis of chicken blood meal on soluble protein content, peptide content, the degree of hydrolysis
and the inhibition of the Angiotensin I - Converting Enzyme (ACE). The results showed that soluble protein, peptide content and
the degree of hydrolysis of the hydrolysates increased when either hydrolysis time or enzyme concentration increased. Five-hour
long hydrolysis, using 10% Alcalase enzyme produced the highest ACE-inhibition activities. Under these conditions, the Alcalase
IC50 value at 0.34 mg peptide/mL was significantly lower than that obtained from other combinations of enzyme, concentration and
hydrolysis time. Separation of the hydrolysates by ultrafiltration isolated a fraction (F3) of less than 3000 Da molar mass. The F3
fraction performed with an IC50 value of only 0.06 mg peptide/mL. Further separation by FPLC using a Superdex peptide 10/300 GL
gel column produced the highest inhibitory efficiency ratio (1071%/mg/mL). These results suggest that chicken blood hydrolysates
can potentially be developed as functional food products in the future.
Key words: chicken blood, hydrolysates, angiotensin converting enzyme inhibition

INTRODUCTION
Modern dietary habits have led to an increase in the
prevalence of cardiovascular diseases. This is evident
from the fact that hypertension-related diseases account
for half of the ten most common causes of death(1). The
Renin-Angiotensin-Aldosterone system controls the
body’s blood pressure. The angiotensin I-converting
enzyme (ACE) plays an important role in this system,
using hydrolysis to convert non-active angiotensin I in
blood into its active form, angiotensin II. This, in turn,
causes blood vessels to contract and blood pressure to
rise. In addition, ACE deactivates bradykinin, a nonapeptide that causes blood vessels to extend, by removing
amino acids from its C-terminus, hence also causing
blood pressure to rise. Thus, successful repression of
ACE activity will lower blood pressure (2,3).
Commonly prescribed medications for hypertension include Captopril, Enalapril, and Lisinopril, all
of which are ACE inhibitors (ACEIs). However, they
commonly cause side effects such as coughing and dizziness. Physiological and biochemical research in recent
years have shown that protein in food is not only a source
of amino acids, but can also provide bio-active peptides
* Author for correspondence. Tel: +886-3-5223191 ext. 368;
Fax: +886-3-5214016; E-mail: hsc30@firdi.org.tw

after digestion or food processing(4). These peptides
can prevent hypertension, oxidation, boost immunity,
fight viral infections and lower cholesterol levels. There
were reports of peptides with ACE inhibitory properties
extracted from food such as beef, pork, chicken, and fish
skin(5,6). Although ACEIs extracted from food are not as
potent as their chemically synthesized counterparts, they
have relatively few side effects (5,6) and are suitable for
daily use as health products.
Chicken blood meal contains 80% of crude proteins,
and its amino acid profile is rich in lysine, arginine,
methionine and cystine (7). Most of the chicken blood
produced during the slaughtering process is processed
into dry food for animals or treated as waste. This is
wasteful and is a potential source of environmental pollution. Hence, using the blood as a resource and product
will help reduce the waste produced from the slaughtering process. In this study, chicken blood hydrolysates
were produced and resolved into different peptide chains
after selective enzymatic hydrolysis. Experiments using
various enzymes and hydrolysis times yielded products
with active ACEIs. By extracting the most active ACEIs
from blood, the production of chicken blood hydrolysates with anti-hypertensive properties was optimized.
The development of chicken blood as a possible health
product or food supplement was discussed.
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MATERIALS AND METHODS
I. Composition of Chicken Blood Meal
The crude protein, crude fat, carbohydrate, ash and
moisture content of chicken blood meal were analyzed
using AOAC official methods (8-11).
II. Preparation of Chicken Blood Meal Hydrolysates
Fresh chicken blood was acquired from Chareon
Pokphand Enterprise, Nantou, Taiwan. The bloodstock
was supplemented with 3.8% sodium citrate (an anticoagulant), frozen for 48 hours before being processed
into chicken blood meal, and stored at -20°C.
Chicken blood meal (2.25 g) was dissolved in phosphate buffered saline (PBS) (25 mL, 10 mM, pH 7.4) and
centrifuged at 7520 ×g, 4°C, 20 min to obtain the supernatant. Protein concentrations were assessed and adjusted
to 40 mg/mL. Alcalase, Prozyme 6, Protease N or Thermolysin was added at 0.5%, 1%, and 10% (w/w, by protein
content). At the reaction temperature of 50°C, the pH of the
proteases were as follows: Alcalase, pH 8; Prozyme-6, pH
7; Protease-N, pH 8 and Thermolysin, pH 8. The mixture
was allowed to react for 2 or 5 h, then placed in boiling
water for 15 min to deactivate the enzymes and terminate
the reaction. The hydrolysates were placed in an ice bath to
cool. Centrifugation (13000 ×g, 5 min) was performed to
obtain the supernatant, which were stored at 4°C.
III. Hydrolysates Analysis
(I) Soluble Protein Content
The Lowry method was used to determine the protein
content of the hydrolysates(12). This method is based on
the reaction of Folin phenol reagent with protein chain
tyrosine residues(13). Diluted samples of hydrolysates
(5 μL) were mixed with 25 μL of Reagent A and 200 μL
of Reagent B (Bio-Rad Dc Protein Assay Kit) and allowed
to settle in the absence of light for 15 min. The optical
density at 750 nm was determined using an ELISA reader.
The soluble protein content in mg/mL was calculated from
a standard curve obtained from bovine serum albumin.
(II) Peptide Content
o-Phthaldialdehyde indicators (OPA) react with
amines in proteins, peptides and amino acids. Thus, OPA
is suitable as a test for the peptide content in hydrolysates(14). The hydrolysates were filtered through 0.45-μm
filters and then diluted. Diluted hydrolysate samples
(5 μL) were extracted, mixed with OPA (200 μL), shaken
and allowed to settle in the dark for two min. The optical
density at 340 nm was compared against a standard curve
obtained from Leu-Gly, and the peptide content in mg/mL
was determined.

(III) Degree of Hydrolysis
The degree of hydrolysis (DH) was estimated by the
change in peptide content and expressed as (15):
DH (%) = [1 - (peptide content at start/peptide content
after hydrolysis)] × 100
IV. Hydrolysate Inhibition of ACE Activity
(I) Testing of ACE Inhibition
Analysis of ACE inhibition of hydrolysates was
performed with reference to the methods reported by
Cushman and Cheung(16). Hydrolysates (75 μL) diluted
with boric acid (100 mM) were mixed and shaken with
ACE enzymes (75 μL) and placed in a water bath at 37oC
for 10 min before being combined with HHL (75 μL). The
mixture was placed in the water bath again for 30 min.
HHL (250 μL) was then added to terminate the reaction.
The product, hippuric acid, was extracted using ethyl
acetate (750 μL), shaken for 1 min and centrifuged at
3600 ×g, 5 min. 500 μL of the supernatant was filtered
using a 0.45-μm filter and evaporated in an open vessel at
80°C. The residue was combined with de-ionized water
(1 mL). 200 μL of the resulting solution was transferred
to a 96-well UV plate. Optical density was measured at
228 nm to determine the extent of ACE inhibition.
(II) Testing of ACE IC50 Values
The hydrolysates were diluted using buffer solutions or de-ionized water to test for ACE inhibition. To
determine 50% inhibition rates (IC50), data for 40-60%
inhibition rates for three levels of peptide content was
used to find the most suitable curvilinear regression. The
resulting formula was applied to determine the peptide
content required to achieve IC50.
(III) Calculation of ACE IER Values
If ACE inhibition is lower than 50% and IC50 values
cannot be found directly, inhibitory efficiency ratio
(IER) values may be used instead. The hydrolysates were
diluted using buffer solutions or de-ionized water to an
appropriate concentration for the determination of protein
content and ACE inhibition rate. The rate was divided by
the peptide content to obtain the IER. This provided an
estimate for ACE activity. IER and ACE are proportional,
so a high IER means greater ACE inhibition.
V. Ultra-Filtration of Hydrolysates
The group of hydrolysates with the greatest ACE
inhibition IC50 values was processed using ultra-filtration. The molecular weight cut-off method (MWCO)
was used to differentiate the larger molecular weights.
The hydrolysates were filtered through two different
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membrane filters (MWCOs of 10 KDa and 3 KDa) and
centrifuged (5000 ×g, 30 min) to separate into three
parts: MWCO of larger than 10 KDa, 3 - 10 KDa and
below 3 KDa. The isolated products were then collected
for further ACE inhibition testing.
VI. Fast Performance Liquid Chromatography (FPLC)
Each molar mass group of hydrolysates was eluted
by FPLC using Superdex peptide 10/300 GL tubes (Pharmacia, USA) (MW: 7000-100, size 1.0 × 30 cm). The
fractions were individually frozen and dehumidified.
Forty milligrams of the meal with the highest ACE IC50
values was extracted and buffered using 1 mL PBS and
run through 0.22-μm filters to extract 100 μL of liquid
sample for analysis. Phosphoric acid (0.05 M) and NaCl
(0.15 M) were used as the PBS. A flow of 0.5 mL/min
and a pressure of 0.58 MPa were used to differentiate the
collected liquid (1 mL per tube). The optical density at
215 nm was analyzed to determine the molecular distribution in each group of hydrolysates. The molecular
weight standards used were: Insulin B chain, 3495.9 Da;
Gastrin I, 2126 Da; Substance P, 1348 Da and Glycine, 75
Da.
VII. Testing Fractions for ACE Inhibition
Optical density measurements produced five peaks
representing different molecular masses. Samples of each
peak were collected, frozen, dehumidified, and dissolved
in buffer solutions and filtered through 0.22-μm filters
before testing for ACE inhibition.
VIII. Statistical Analysis
Data was analyzed using the Duncan test with the
Statistical Package for the Social Sciences (SPSS). A value
of p < 0.05 was considered to be statistically significant.

RESULTS AND DISCUSSION
I. Composition of Chicken Blood Meal
Chicken blood meal contains 65.73% crude protein,
7.71% crude fat, 7.52% carbohydrate, 1.42% moisture and
17.62% ash (Table 1). The crude protein in chicken blood

Table 1. Composition of chicken blood meal
Item

Crude Protein
(g/100 g)

Crude Fat
(g/100 g)

Moisture
(g/100 g)

Ash
(g/100 g)

Blood Meal* 65.73 ± 0.91 7.71 ± 0.03 1.42 ± 0.22 17.62 ± 0.33
* Values represent means ± standard deviation of three replicate
analyses (n = 3).

meal is higher than those in chicken bone (23.54%)(15)
and breast meat (22%)(17). Blood from domestic chickens
is a suitable source of soluble protein for the health
product industry.
II. Changes in Conditions for the Hydrolysis of Different
Enzymes
(I) Effect of Hydrolysis Time on Chicken Blood Meal
Hydrolysates
Alcalase, Prozyme 6 and Protease-N were used
in the hydrolysis of chicken blood meal for 2 and 5 h.
Soluble protein levels, peptide content, degree of hydrolysis and extent of ACE inhibition (Figure 1A) were
tested. For the three proteases, soluble protein concentration increased with the duration of hydrolysis. The use of
10% Alcalase and 10% Prozyme-6 attained the highest
levels of soluble proteins, approximately 34 mg/mL,
after 5 h of hydrolysis. Hydrolysis of clam protein using
Protamex showed similar results (18). This suggested that
prolonged reaction with proteases hydrolysed the otherwise insoluble high molecular weight proteins. Continued
hydrolysis cleaved the longer chain, high molecular
weight proteins into many smaller peptides. Each
cleavage exposed an additional N- and C-terminus and
resulted in higher levels of soluble proteins and smaller
peptide chains, thus increasing the solubility(19).
As seen in Figure 1B, longer periods of hydrolysis also increased peptide content. Figure 1C demonstrates increased hydrolysis with time for all groups. 10%
Prozyme-6 reacting for 5 h achieved the highest peptide
concentration (34 mg/mL, 96%). Other enzymes and conditions showed lower performances. Increased hydrolysis
also resulted in an increase in amino nitrogen content(20).
The soluble protein content, peptide content and degree
of hydrolysis of chicken blood meal hydrolysates were all
higher for the three enzymes than the control group. ACE
inhibition results in Figure 1D suggest that there is a positive correlation between the time allowed for hydrolysis
and the extent of ACE inhibition. ACE inhibition after a
ten-to-one dilution showed that hydrolysis with Alcalase
for 5 h produced the best results (91%). Other test groups
also showed noticeable differences.
(II) Effect of Protease Concentration on Chicken Blood
Meal Hydrolysates
Experiments to study the effects of varying protease
concentration from 1% to 10% on blood meal hydrolysates
found that soluble protein levels increased with protease
concentration for all molar mass hydrolysate groups, with
10% Alcalase and 10% Prozyme 6 yielding the highest
results (Figure 1A). Peptide content and degree of hydrolysis also increased with protease concentration (Figures
1B and 1C). As the hydrolysis reactions proceeded,
changes in the enzyme concentration to substrate ratio
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Figure 1. Effects of various chicken blood meal hydrolysates treated with different proteases and times: (A) soluble protein, (B) peptide
content, (C) degree of hydrolysis, and (D) ACE inhibition.* Control: The means shown in Figures (A) and (B) were obtained without the addition of enzymes in Figure (D) was obtained using 0.01 μg/mL Captopril. The data in this figure represents the mean ± standard deviation (n =
3). The means (bar value) with different letters are significantly different (p < 0.05).

affected the rate of hydrolysis. Thus, it was observed that
protease concentration affected the hydrolysis reaction
and the higher the concentration of protease, the higher
the rate of reaction. Hydrolysis with 10% Alcalase for five
hours showed the greatest ACE inhibitory activity of 91%
(Figure 1D). Alcalase is an alkaline protease for industrial
applications, produced from Bacillus licheniformis. The
main enzyme component of Alcalase is subtilisin Carlsberg (a serine protease)(21). This study showed that hydrolysates produced from the hydrolysis of Alcalase achieved
the highest inhibition of ACE (20). Other studies had also
used Alcalase in the hydrolysis of bovine plasma proteins,
which produced better ACE suppressants than other products of enzymatic hydrolysates(21).
III. 50% Inhibition of ACE (IC50) by Chicken Blood Meal
Hydrolysates
It was of interest to study the peptide concentration
required for 50% inhibition of ACE activity, also known
as the IC50 value. Preliminary measurements of the
soluble protein content, peptide content and the degree of
hydrolysis showed that chicken blood hydrolysed for 5 h
with 10% Alcalase gave the lowest ACE IC50 values. The
results showed that with a 2% concentration of Alcalase,
the ACE IC50 was only 1.83 mg peptide/mL (Table 2). In
addition, better inhibition results required concentrations greater than 4% and the lowest observed IC50 value
of 0.34 mg peptide/mL was obtained from the hydrolysis
of blood meal with 10% Alcalase (Table 2). Notably, the

IC50 value of the control group, Captopril (0.01 μg/mL),
was 0.0004 mg peptide/mL. At this point in the work,
the hydrolysates were not pure. After identifying the
most promising candidates, ultra-filtration was applied to
obtain the compounds in the pure form.
IV. ACE IC50 Values of Ultra-Filtration Samples
After selecting the most promising blood hydrolysates, three groups (F1-3) were prepared using centrifugal
ration: F1 (> 10,000 Da), F2 (3,000 - 10,000 Da) and F3
(< 3000 Da). The groups were tested for ACE inhibition and F3 showed the lowest IC50 values (IC50 = 0.06
mg peptide/mL, approximately 0.22 mg/mL) (Table 3).
F3 was isolated using a UF membrane with a 3000 Da
molecular weight cutoff. Theoretically, this membrane
could allow peptides of less than 22 amino acids
(assuming that the average MW of amino acids is 137
Da) to pass through and be collected in the permeate (22).
F1 showed the lowest performance with IC50 = 0.47
mg peptide/mL. This was due to the presence of large
proteins, which had a lower combination frequency
with ACE. In fact, F1 showed poorer results than the
un-grouped hydrolysates. With the exception of the
high IC50 values of F1, IC50 values decreased in parallel
with the group molecular weights. From this, it can be
deduced that the most effective inhibitory compounds
are among peptides of lower molecular weights. Previous
studies presented similar findings: centrifugal filtration of protease hydrolysates in beef increased ACE
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Table 2. Changes in ACE inhibitory activity as IC50* values during
the hydrolysis of chicken blood meal
Treatment

Time (h)

IC50 (mg peptide/mL)

Control**

5

0.004 ± 0.01a***

2.0% Alcalase

5

1.83 ± 0.43f

4.0% Alcalase

5

0.86 ± 0.09cde

6.0% Alcalase

5

0.64 ± 0.31bcd

8.0% Alcalase

5

0.47 ± 0.25bc

10% Alcalase

5

0.34 ± 0.23b

10% Prozyme 6

5

1.16 ± 0.06e

10% Protease N

5

0.98 ± 0.01de

* IC50: The concentration required to inhibit 50% of the ACE
activity.
** Control: 0.01μg/mL Captopril.
*** Data represents mean ± standard deviation (n = 3). Values in the
same column with different letters are significantly different
(p < 0.05).
Table 3. The ACE inhibitory activity of chicken blood hydrolysates
separated by ultra filtration
Fraction
No.

Molecular
Weight
(Da)

1

>10000

2

Inhibitory
(%)

Peptide
Conc.
(mg/mL)

85.23 ± 0.17 8.41 ± 0.10 0.47 ± 0.006a**

10000 - 3000 92.53 ± 0.19 7.71 ± 0.07

3

< 3000

IC50
(mg peptide/mL)

93.29 ± 0.41 5.16 ± 0.02

0.18 ± 0.001b
0.06 ± 0.002c

* IC50: The concentration required to inhibit 50% of the ACE
activity.
** Data represents mean ± standard deviation (n = 3). Values in the
same column with different letters are significantly different
(p < 0.05).

Table 4. The ACE inhibitory activity of peptide fractions separated
by Superdex peptide 10 / 300 gel chromatography
Peak No.

Molecular
Weight (Da)

Peptide Conc.
(mg/mL)

IER*
(%/mg/mL)

1

2410 - 1570

0.165 ± 0.021

227.45 ± 2.23a**

2

1440 - 1370

0.132 ± 0.032

252.12 ± 0.85b

3

1300 - 1160

0.085 ± 0.007

361.17 ± 0.74c

4

1020 - 880

0.052 ± 0.002

716.41 ± 1.56d

5

470 - 190

0.024 ± 0.001

1071.66 ± 1.03e

* IER (inhibitory efficiency ratio) = % inhibition/ peptide concentration (mg/mL).
** Data represents mean ± standard deviation (n = 3). Values in the
same column with different letters are significantly different
(p < 0.05).

inhibition(23), filtration of protease hydrolysates of
chicken breast, which produced fractions with a molecular weight less than 1000 Da, had superior ACE inhibition(24), protease hydrolysate collagen extracts of chicken
feet showed better results in solutions containing proteins
of less than 3000 Da in molecular weight (25), and the
use of different fractions of molecular weight in ultrafiltration in the protease hydrolysis of beef plasma can
also increase inhibition(21). In other studies, however,
Alcalase produced ACE inhibitor peptides from bovine
blood plasma proteins and the Alcalase hydrolysate of
albumin showed high activity (IC50 = 0.56 mg/mL)(21).
The hydrolysate produced by the hydrolysis of porcine
red blood corpuscles with a mixture of trypsin, chymotrypsin, and thermolysin exhibited angiotensin
I-converting enzyme (ACE) inhibitory activity (IC50 =
0.58 mg/mL)(22). In accordance with these reports, the F3
(< 3000 Da) group samples showed the best results with
IC50 values of 0.22 mg/mL.
V. ACE IER Values of Chicken Blood Meal Hydrolysates
after Ultra-Filtration and FPLC
The filtrates were frozen after preliminary ultrafiltration. The F3 blood-meal group, with the lowest IC50
value, was run through FPLC with a Superdex peptide
10/300 GL column. PBS buffer was used to differentiate
the molecular weight distribution in the samples.
The results showed that after filtration with
Superdex peptide 10/300 GL, most F3 samples had
average molecular weights of less than 3000 Da. The
larger the mass of the sample, the shorter its elution
time. Conversely, smaller molecule peptides were eluted
last. Five peaks (P1-P5) were obtained from the samples
as determined by optical density measurements at
215 nm. Table 4 shows the results of the determination
of peptide content, ACE inhibition and inhibitory efficiency ratio (IER). The portions with molecular weights
between 2500 - 1200 Da showed little variation in IER
(200 - 250%/mg/mL). In addition, IER increased when
the molecular weight was less than 1000 Da, and P5
(470 - 190 Da) showed the strongest ACE inhibition, with
an IER of 1071%/mg/mL. Multiple studies in recent years
have shown that most peptides with good ACE inhibition
are short peptides of 2 - 10 amino acids(26), and the smaller
the molecule after hydrolysis, the greater the effectiveness
in lowering blood pressure(21). Thus, products with good
ACE inhibition properties contain low molecular weight
peptides. Active small molecule peptides are still unpredictable once they enter the human body. However, studies
have shown that compared to larger peptides, smaller
peptides are more easily absorbed by the large intestine (27).
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